Close Menu

The BCW Index climbed 1.59 percent for the trading week ended Tuesday. Only five of the components of the Index declined for the week, and none of them dropped more than 1.6 percent. Stratagene led gainers for the tracking period, closing up 6.7 percent.

In comparison, the Dow Jones Industrial Average gained .9 percent, while both the Nasdaq and Nasdaq Biotech Index rose 2.6 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.